tiprankstipranks
Trending News
More News >
Silicon Laboratories (SLAB)
NASDAQ:SLAB
Advertisement

Silicon Laboratories (SLAB) AI Stock Analysis

Compare
463 Followers

Top Page

SLAB

Silicon Laboratories

(NASDAQ:SLAB)

Rating:57Neutral
Price Target:
$135.00
▲(1.40% Upside)
Silicon Laboratories' overall stock score is driven by a strong balance sheet and positive earnings call outlook, which are offset by challenges in profitability and cash flow generation. The technical indicators suggest caution, and the valuation is unattractive due to negative earnings and no dividend yield. The company's growth prospects in industrial and commercial segments provide a positive outlook, but financial performance needs improvement.
Positive Factors
Design Wins
Management expressed confidence in outperforming the broader semiconductor market for the year, citing strong design win momentum and a stabilizing market environment.
Earnings
Silicon Labs 2Q results built on its recent momentum and extended its return to solid annual growth, driven by share gains and new program ramps from its industry-leading Series 2 platform.
Market Position
SLAB has consistently earned a premium multiple to the group, owing to its strong fundamental business model and attractive long-term visibility.
Negative Factors
Home & Life Business
Home & Life (H&L) was weaker due to lumpiness in customer programs.
Inventory
Channel inventory remains well below the company's target level of 70-75 days, which could affect short-term supply.
Order Visibility
Visibility beyond the current quarter remains somewhat limited as orders are being placed below lead times.

Silicon Laboratories (SLAB) vs. SPDR S&P 500 ETF (SPY)

Silicon Laboratories Business Overview & Revenue Model

Company DescriptionSilicon Laboratories Inc., a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the Internet of Things (IoT), including connected home and security, industrial automation and control, smart metering, smart lighting, commercial building automation, consumer electronics, asset tracking, and medical instrumentation. The company sells its products through its direct sales force, as well as through a network of independent sales representatives and distributors. Silicon Laboratories Inc. was founded in 1996 and is headquartered in Austin, Texas.
How the Company Makes MoneySilicon Laboratories generates revenue through the sale of its semiconductor products, which include microcontrollers, wireless connectivity solutions, and sensors. The company's revenue model is predominantly based on product sales to original equipment manufacturers (OEMs) and other technology companies. Key revenue streams include IoT solutions, which are increasingly in demand as more devices become connected, and automotive solutions that cater to the growing need for advanced automotive electronics. Additionally, Silicon Labs has established significant partnerships with major technology firms, which enhance its market reach and product integration capabilities, further contributing to its earnings. The company's focus on innovation and development of cutting-edge technology helps maintain its competitive advantage and drives revenue growth.

Silicon Laboratories Earnings Call Summary

Earnings Call Date:Aug 05, 2025
(Q2-2025)
|
% Change Since: -0.31%|
Next Earnings Date:Oct 29, 2025
Earnings Call Sentiment Positive
Silicon Labs exhibited strong revenue growth driven by successful product innovation and execution on design wins, particularly in the industrial, commercial, and home & life segments. Despite some challenges such as an operating loss and inventory management issues, the overall outlook remains positive with significant growth anticipated in the coming quarters.
Q2-2025 Updates
Positive Updates
Strong Revenue Growth
Silicon Labs reported revenue for the June quarter of $193 million, up 9% sequentially and 33% year-over-year. The revenue for the September quarter is anticipated to be in the range of $200 million to $210 million, implying a strong 23% year-over-year growth rate.
Design Win Success
10 out of the 12 largest customer ramps are on track or ahead of plan for 2025. The Series 2 platform continues to drive growth, with significant wins in Bluetooth, Wi-Fi, and commercial building controls.
Product Innovation and Launch
The introduction of the Series 3 device, the 301, as the world's first device to achieve PSA Level 4 security certification, highlights Silicon Labs' innovative edge.
Industrial and Commercial Business Growth
Industrial and Commercial segment revenue was $110 million, up 14% sequentially and 25% year-over-year, driven by electronic shelf labeling and smart meter rollouts.
Home and Life Business Expansion
Home & Life revenue was $83 million, up 2% sequentially and 45% year-over-year, driven by strong demand in smart home applications and connected healthcare, particularly in continuous glucose monitoring applications.
Negative Updates
Operating Loss
GAAP operating loss for the quarter was $23 million, although this was offset by non-GAAP operating income of $1 million.
Channel Inventory Challenges
Channel inventory increased slightly to 51 days, still below the target range of 70 to 75 days, indicating ongoing challenges in inventory management.
Tariff Uncertainty
Ongoing tariff discussions create uncertainty, although the direct impact on supply chains has been minimal so far.
Company Guidance
During the Silicon Labs Second Quarter Fiscal 2025 Earnings Call, the company provided guidance indicating strong financial performance and growth prospects. Revenue for the June quarter reached $193 million, representing a 9% sequential increase and a 33% year-over-year rise. The Industrial and Commercial business contributed $110 million, up 14% sequentially and 25% annually, driven by electronic shelf labeling and smart metering projects. The Home & Life segment generated $83 million, marking a 2% sequential and 45% annual increase, largely due to growth in medical customer designs. Gross margins improved, with GAAP at 56.1% and non-GAAP at 56.3%, both above the previous quarter's midpoint guidance. Looking ahead, Silicon Labs anticipates September quarter revenue between $200 million and $210 million, with a projected year-over-year growth rate of 23% and a sequential increase of 6%. The company expects gross margins to range from 57% to 58%, reflecting continued strength in industrial applications. Silicon Labs remains focused on managing operating expenses, with GAAP operating expenses forecasted between $130 million and $133 million, and non-GAAP expenses between $107 million and $110 million. GAAP loss per share is anticipated to be between $0.60 and $0.20, while non-GAAP earnings per share are expected to be in the range of $0.20 to $0.40.

Silicon Laboratories Financial Statement Overview

Summary
Silicon Laboratories faces challenges in revenue generation and profitability, as indicated by declining income statement metrics. The balance sheet is strong with no debt and a robust equity position, which provides stability and reduces financial risk. Cash flow metrics highlight areas for improvement, particularly in generating positive free cash flow. Overall, while the company has a solid financial base, it needs to address profitability and cash flow generation to enhance its financial health.
Income Statement
45
Neutral
Silicon Laboratories has experienced declining revenue over recent years, with a significant drop from $1.02 billion in 2022 to $584 million in 2024, representing a negative trend. The gross profit margin has also decreased, indicating pressure on profitability. The company has reported negative net income and EBIT margins, highlighting challenges in maintaining profitability.
Balance Sheet
70
Positive
The balance sheet reflects a strong equity position with no total debt in 2024, which is noteworthy for financial stability. The equity ratio has improved, indicating a solid financial foundation. However, the decrease in total assets over time suggests potential challenges in asset management. Overall, the company's low leverage is a positive aspect.
Cash Flow
60
Neutral
Cash flow analysis shows negative free cash flow in the most recent year, which is concerning. The operating cash flow to net income ratio indicates inefficiencies in converting sales into cash. Despite these issues, the company has maintained a reasonable cash balance, supporting liquidity.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue703.20M584.39M782.26M1.02B720.86M886.68M
Gross Profit386.42M312.19M460.59M642.56M425.39M527.53M
EBITDA-54.44M-104.92M46.09M175.85M32.04M-43.28M
Net Income-104.61M-191.01M-34.52M91.40M-71.60M12.53M
Balance Sheet
Total Assets1.22B1.22B1.44B2.17B2.96B1.99B
Cash, Cash Equivalents and Short-Term Investments415.54M382.16M439.22M1.19B2.04B724.68M
Total Debt0.0015.55M64.83M529.57M450.60M563.42M
Total Liabilities159.99M142.65M234.37M764.42M745.87M793.65M
Stockholders Equity1.06B1.08B1.21B1.41B2.21B1.20B
Cash Flow
Free Cash Flow75.07M-25.66M-52.63M45.28M-129.02M115.30M
Operating Cash Flow94.79M-13.91M-30.35M71.81M-100.44M135.72M
Investing Cash Flow-22.04M113.12M469.81M240.54M2.27B-361.01M
Financing Cash Flow868.00K-45.10M-711.87M-887.05M-1.30B200.87M

Silicon Laboratories Technical Analysis

Technical Analysis Sentiment
Positive
Last Price133.14
Price Trends
50DMA
138.16
Negative
100DMA
124.39
Positive
200DMA
125.53
Positive
Market Momentum
MACD
-3.02
Positive
RSI
51.12
Neutral
STOCH
66.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SLAB, the sentiment is Positive. The current price of 133.14 is below the 20-day moving average (MA) of 134.37, below the 50-day MA of 138.16, and above the 200-day MA of 125.53, indicating a neutral trend. The MACD of -3.02 indicates Positive momentum. The RSI at 51.12 is Neutral, neither overbought nor oversold. The STOCH value of 66.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SLAB.

Silicon Laboratories Risk Analysis

Silicon Laboratories disclosed 37 risk factors in its most recent earnings report. Silicon Laboratories reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Silicon Laboratories Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$2.62B14.47-3.34%11.98%-138.59%
60
Neutral
$4.57B-93.41%13.83%88.14%
57
Neutral
€1.69B12.191.59%3.67%2.96%-106.86%
57
Neutral
$4.29B-9.71%29.66%47.97%
55
Neutral
$2.59B78.494.68%1.76%7.16%-21.24%
55
Neutral
$5.63B-9.17%65.12%15.46%
53
Neutral
$5.75B-6.75%-18.82%-195.20%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SLAB
Silicon Laboratories
133.14
28.72
27.50%
POWI
Power Integrations
47.26
-17.00
-26.46%
SMTC
Semtech
50.52
14.56
40.49%
SYNA
Synaptics
68.03
-8.46
-11.06%
SITM
SiTime Corporation
226.74
86.88
62.12%
ALGM
Allegro MicroSystems
31.10
5.98
23.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 13, 2025